Shattuck Labs (STTK) Treasury Shares (2019 - 2026)
Shattuck Labs (STTK) reported Treasury Shares of $589803.0 for Q1 2026, up 11.82% year-over-year from $527453.0 in Q1 2025, and up 22.58% quarter-over-quarter from $481177.0 in Q4 2025.
Shattuck Labs (STTK) Treasury Shares (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Treasury Shares data on file, last reported at $589803.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $589803.0, up 11.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $589803.0 (up 11.82% YoY), and the FY2025 annual result was $481177.0, down 41.13% from the prior year.
- Treasury Shares grew to $589803.0 in Q1 2026 per STTK's latest filing, from $481177.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.0 million in Q1 2024 and troughed at $295977.0 in Q3 2022.
- A 5-year average of $605454.9 and a median of $589803.0 in 2026 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares jumped 18417.7% in 2022, then tumbled 52.29% in 2025.
- A 5-year view of Treasury Shares shows it stood at $309477.0 in 2022, then jumped by 90.77% to $590403.0 in 2023, then jumped by 38.44% to $817350.0 in 2024, then plunged by 41.13% to $481177.0 in 2025, then advanced by 22.58% to $589803.0 in 2026.
- Business Quant data shows STTK's Treasury Shares at $589803.0 in Q1 2026, $481177.0 in Q4 2025, and $481177.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 589,803.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 589,803.00 |
| Mar 31, 2026 | 589,803.00 |
| Dec 31, 2025 | 481,177.00 |
| Dec 31, 2025 | 481,177.00 |
| Sep 30, 2025 | 481,177.00 |
| Sep 30, 2025 | 481,177.00 |
| Jun 30, 2025 | 517,848.00 |
| Jun 30, 2025 | 517,848.00 |
| Mar 31, 2025 | 527,453.00 |
| Mar 31, 2025 | 527,453.00 |
| Dec 31, 2024 | 817,350.00 |
| Dec 31, 2024 | 817,350.00 |
| Sep 30, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 590,403.00 |
| Dec 31, 2023 | 590,403.00 |